Departments & Centers

Offers comprehensive treatments for various hematologic and lymphoid tissue diseases such as malignant lymphoma, acute and chronic leukemia, hematopoietic malignant tumors such as multiple myeloma, anemia, thrombocytopenia and bleeding disorders.

Specialists in the field working in our department will actively promote hematopoietic stem cell transplantation to treat hematopoietic malignant tumors.
Hematopoietic stem cell transplantation is a treatment for patients with hematopoietic malignant tumors such as leukemia, which can be difficult to treat with chemotherapy, and other diseases where the body is unable to produce normal blood cells; by transplanting stem cells from a healthy donor after anti-cancer and systemic radiotherapy treatment, thereby enabling patients to create normal blood cells again.

Highlights of the department

• Treatment using a new type medication called “molecular targeting agents” will be offered in addition to chemotherapy using anti-cancer drugs.
• Chemotherapy, which causes bone marrow suppression to a high degree and hematopoietic stem cell transplantation, will be offered as treatment for hematopoietic malignant tumors. This treatment requires dedicated sterile treatment environment, and we have a sterile treatment room equipped with 36 beds, which is one of the best facilities in Japan.
• Coordination with community hospitals is vital in order to promote hematopoietic stem cell transplantation in an active manner. We will also offer treatments in close coordination with community hospitals.